Analyst Colleen M. Kusy of Robert W. Baird maintained a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), retaining the ...

ANI Pharmaceuticals (ANIP) announced that following final approval from the U.S. FDA for its Abbreviated New Drug Application, the company ...

ANI Pharmaceuticals (NASDAQ:ANIP) announced that following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application, the company launched Estradiol Gel, 0.06% ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration ...

TATA AIG General Insurance Company Limited and Dun & Bradstreet India released the Horizon Watch Emerging Risk Report, a collaborative research effort identifying and analysing emerging risks that ...

PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- (ANI or the Company) (Nasdaq: ANIP) today announced that following final ...

Gujarat welcomed Spanish Prime Minister Pedro Sanchez Perez-Castejon on Thursday His visit for the inauguration of the Tata-Airbus manufacturing facility in ...

Two poster presentations demonstrate ANI's commitment to research in membranous nephropathy care ...

ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) had its price objective lifted by equities researchers at Truist Financial from $60.00 to $62.00 in a report released on Tuesday, Benzinga reports.

Truist raised the firm’s price target on ANI Pharmaceuticals (ANIP) to $62 from $60 and keeps a Hold rating on the shares as ...

In October, a Chennai-based company gifted its staff up to 28 cars and 29 bikes as a Diwali gifts. According to an official, ...

Vinay Kumar stated that India is a founding member of BRICS and is committed to economic cooperation within the framework of ...